Skip to main content
. 2018 Jul 20;82(4):585–592. doi: 10.1007/s00280-018-3648-y

Table 2.

Phase II patient characteristics

Total number of patients 28
Median age (range, years) 65 (33–76)
Disease status
 Advanced 5
 Recurrent 23
Histology
 Endometrioid
  G1 1
  G2 8
  G3 8
 Serous 4
 Clear cell 3
 Poorly differentiated 1
 Mixed 1
 Carcinosarcoma 2
Previous radiotherapy
 Yes 4
 No 24
Taxane/platinum regimen
 TC 17
 TEC 7
 TAC 4
 AP 3
 DC 1
Response to taxane/platinum regimen
 Refractory 6
 Resistant 22